Literature DB >> 24750341

Predicting mortality in people with type 2 diabetes mellitus after major complications: a study using Swedish National Diabetes Register data.

P J Kelly1, P M Clarke, A J Hayes, U-G Gerdtham, J Cederholm, P Nilsson, B Eliasson, S Gudbjornsdottir.   

Abstract

AIM: To predict mortality risk and life expectancy for patients with type 2 diabetes after a major diabetes-related complication.
METHODS: The study sample, taken from the Swedish National Diabetes Register, consisted of 20 836 people with type 2 diabetes who had their first major complication (myocardial infarction, stroke, heart failure, amputation or renal failure) between January 2001 and December 2007. A Gompertz proportional hazards model was derived which determined significant risk factors associated with mortality and was used to estimate life expectancies.
RESULTS: Risk of death changed over time according to type of complication, with myocardial infarction initally having the highest initial risk of death, but after the first month, the risk was higher for heart failure, renal failure and amputation. Other factors that increased the risk of death were male gender (hazard ratio 1.06, 95% CI 1.02-1.12), longer duration of diabetes (hazard ratio 1.07 per 10 years, 95% CI 1.04-1.10), smoking (hazard ratio 1.51, 95% CI 1.40-1.63) and macroalbuminuria (hazard ratio 1.14, 95% CI 1.06-1.22). Low BMI, low systolic blood pressure and low estimated GFR also increased mortality risk. Life expectancy was highest after a stroke, myocardial infarction or heart failure, lower after amputation and lowest after renal failure. Smoking and poor renal function were the risk factors which had the largest impact on reducing life expectancy.
CONCLUSIONS: Risk of death and life expectancy differs substantially among the major complications of diabetes, and factors significantly increasing risk included smoking, low estimated GFR and albuminuria.
© 2014 The Authors. Diabetic Medicine © 2014 Diabetes UK.

Entities:  

Mesh:

Year:  2014        PMID: 24750341     DOI: 10.1111/dme.12468

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  13 in total

Review 1.  Relation of Smoking With Total Mortality and Cardiovascular Events Among Patients With Diabetes Mellitus: A Meta-Analysis and Systematic Review.

Authors:  An Pan; Yeli Wang; Mohammad Talaei; Frank B Hu
Journal:  Circulation       Date:  2015-08-26       Impact factor: 29.690

2.  Foot Complications and Mortality: Results from Translating Research Into Action for Diabetes (TRIAD).

Authors:  Laura N McEwen; Kelly R Ylitalo; Michael Munson; William H Herman; James S Wrobel
Journal:  J Am Podiatr Med Assoc       Date:  2016 Jan-Feb

3.  Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM).

Authors:  Michael Willis; Pierre Johansen; Andreas Nilsson; Christian Asseburg
Journal:  Pharmacoeconomics       Date:  2017-03       Impact factor: 4.981

4.  Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study.

Authors:  D Martinez-Laguna; X Nogues; B Abrahamsen; C Reyes; C Carbonell-Abella; A Diez-Perez; D Prieto-Alhambra
Journal:  Osteoporos Int       Date:  2017-07-25       Impact factor: 4.507

5.  Cardio-ankle vascular index is associated with cardiovascular target organ damage and vascular structure and function in patients with diabetes or metabolic syndrome, LOD-DIABETES study: a case series report.

Authors:  Manuel Ángel Gómez-Marcos; José Ignacio Recio-Rodríguez; María Carmen Patino-Alonso; Cristina Agudo-Conde; Leticia Gómez-Sánchez; Marta Gomez-Sanchez; Emiliano Rodríguez-Sanchez; Jose Angel Maderuelo-Fernandez; Luís García-Ortiz
Journal:  Cardiovasc Diabetol       Date:  2015-01-16       Impact factor: 9.951

6.  Long-Term Administration of Dehydroepiandrosterone Accelerates Glucose Catabolism via Activation of PI3K/Akt-PFK-2 Signaling Pathway in Rats Fed a High-Fat Diet.

Authors:  Jian Kang; Chongyang Ge; Lei Yu; Longlong Li; Haitian Ma
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

7.  Hyperglycemia and diabetes have different impacts on outcome of ischemic and hemorrhagic stroke.

Authors:  Katarzyna K Snarska; Hanna Bachórzewska-Gajewska; Katarzyna Kapica-Topczewska; Wiesław Drozdowski; Monika Chorąży; Alina Kułakowska; Jolanta Małyszko
Journal:  Arch Med Sci       Date:  2016-06-30       Impact factor: 3.318

8.  Leukocyte telomere length and mortality risk in patients with type 2 diabetes.

Authors:  Anna Rita Bonfigli; Liana Spazzafumo; Francesco Prattichizzo; Massimiliano Bonafè; Emanuela Mensà; Luigina Micolucci; Angelica Giuliani; Paolo Fabbietti; Roberto Testa; Massimo Boemi; Fabrizia Lattanzio; Fabiola Olivieri
Journal:  Oncotarget       Date:  2016-08-09

9.  Proteomics reveals changes in hepatic proteins during chicken embryonic development: an alternative model to study human obesity.

Authors:  Mengling Peng; Shengnan Li; Qianian He; Jinlong Zhao; Longlong Li; Haitian Ma
Journal:  BMC Genomics       Date:  2018-01-08       Impact factor: 3.969

10.  Effects of chromium malate on glycometabolism, glycometabolism-related enzyme levels and lipid metabolism in type 2 diabetic rats: A dose-response and curative effects study.

Authors:  Weiwei Feng; Guanghua Mao; Qian Li; Wei Wang; Yao Chen; Ting Zhao; Fang Li; Ye Zou; Huiyu Wu; Liuqing Yang; Xiangyang Wu
Journal:  J Diabetes Investig       Date:  2015-04-15       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.